Daniela Thommen
danielathommen.bsky.social
Daniela Thommen
@danielathommen.bsky.social
Precision cancer immunotherapy, T cell immunology, patient-derived tumor immune models | Group leader at NKI and Oncode Institute Amsterdam
Are exhausted T cells functionless? Absolutely not! We found that dysfunctional T cells are key initiators of early tissue responses to PD-1 blockade and equipped to rapidly regain anti-tumor function via restoration of translational control. See new preprint from the lab led by Paulien Kaptein
September 28, 2025 at 10:49 AM
Very proud of our postdoc @christinamt.bsky.social @nkinl.bsky.social who was awarded an EACR-Mark Foundation Postdoctoral Fellowship! Congratulations to the other awardees and thanks to @helloeacr.bsky.social and @themarkfdn.bsky.social for this fantastic support!
Congratulations to our first EACR-@themarkfdn Postdoctoral Fellowship winners! Julie Mazet, Christina Metoikidou and Martha Zarou 👏

This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe.

magazine.eacr.org/congratulati...
March 19, 2025 at 6:14 PM
Reposted by Daniela Thommen
Well done to the first recipients of the EACR-Mark Foundation postdoc fellowships 🎉🎊

And a happy coincidence that all three awardees are women scientists in the labs of three women PIs 🙌

#WomeninSTEM #WomeninScience 👩‍🔬👩🏻‍🔬🧪

@themarkfdn.bsky.social
@helloeacr.bsky.social
@juliemmazet.bsky.social
Congratulations to our first EACR-@themarkfdn Postdoctoral Fellowship winners! Julie Mazet, Christina Metoikidou and Martha Zarou 👏

This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe.

magazine.eacr.org/congratulati...
March 19, 2025 at 10:33 AM
Reposted by Daniela Thommen
For those who couldn't attend the new #AACRIO25 meeting, check out our digest here 👉 bit.ly/3XvBUkp. We included talks from @jimallisonphd.bsky.social, @danielathommen.bsky.social, @jcstark.bsky.social and more! (1/2)
March 5, 2025 at 4:30 PM
Reposted by Daniela Thommen
📚 In conjunction with #ESMOImmuno24, we had our annual #ESMO #IOTECH Editorial Board meeting today - delighted to see many more academics now here 🦋.

🎯 EiC: @haanenjohn.bsky.social

Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...
Gutted not to be Geneva 🇨🇭 for #ESMOImmuno24 in person this year 🥹.

If you are presenting your work at #ESMOImmuno24, and potentially looking for a home for your research work, please consider submitting to our ESMO IOTECH journal:
🔗 esmoiotech.org
December 12, 2024 at 7:30 PM
Reposted by Daniela Thommen
🎬 Fantastic start to #ESMOImmuno24 with ESMO-SITC primer. Highlighting challenges of IO biomarker discovery:

🔴 Heterogeneity in data, samples and assay types
🧬 Need for cross-study harmonisation & tailored composite biomarkers
💊 Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!
December 11, 2024 at 9:38 AM
Reposted by Daniela Thommen
Future PhD students, check out our NKI PhD program: bsky.app/profile/nkin...
📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjq
November 29, 2024 at 1:16 PM